Elite Pharmaceuticals Inc. (ELTP)
OTCQB OTCQB Primary Summary
ELTP Chart
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
Northvale, New Jersey--(Newsfile Corp. - June 16, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company engaged in the development, manufacture, and distribution of niche generic products, today reported positive results from a pivotal bioequivalence study for an undisclosed anticoagulant generic drug product. IQVIA reported branded product sales for the twelve months ending April 2025 of $27 billion.
Elite Pharmaceuticals Announces Commercial Launch of Oxycodone and Acetaminophen Tablets
Northvale, New Jersey--(Newsfile Corp. - April 30, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, today announced that the company has launched Elite's generic version of Percocet® (oxycodone hydrochloride and acetaminophen tablets, USP CII) 5mg/325mg, 7.5mg/325mg and 10mg/325mg tablets. Oxycodone HCl and acetaminophen is indicated for the relief of moderate to moderately severe pain.
Elite Pharmaceuticals, Inc. Announces First Shipment of Product from New Facility and Packaging Line
Northvale, New Jersey--(Newsfile Corp. - March 3, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, announced today the shipment of its first lot of finished product from its new FDA-approved expanded campus. The new facility, located at 144 Ludlow Avenue in Northvale, New Jersey, includes packaging, inventory and warehouse space.
Elite Pharmaceuticals Inc. Dividends
Elite Pharmaceuticals Inc. Earnings
| 12 Aug 2025 (55 Days) Date | | - Cons. EPS | - EPS |
| 12 Feb 2025 Date | | - Cons. EPS | - EPS |
| 14 Nov 2024 Date | | - Cons. EPS | - EPS |
| 14 Aug 2024 Date | | - Cons. EPS | 0 EPS |
| 29 Jun 2024 Date | | - Cons. EPS | - EPS |
| 12 Aug 2025 (55 Days) Date | | - Cons. EPS | - EPS |
| 12 Feb 2025 Date | | - Cons. EPS | - EPS |
| 14 Nov 2024 Date | | - Cons. EPS | - EPS |
| 14 Aug 2024 Date | | - Cons. EPS | 0 EPS |
| 29 Jun 2024 Date | | - Cons. EPS | - EPS |
Elite Pharmaceuticals Inc. (ELTP) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
What is the earnings per share?
When is the next earnings date?
Has Elite Pharmaceuticals Inc. ever had a stock split?
Elite Pharmaceuticals Inc. Profile
| Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Mr. Nasrat Hakim CEO | OTCQB Exchange | US28659T2006 ISIN |
| US Country | 53 Employees | - Last Dividend | - Last Split | 23 Jul 1998 IPO Date |
Overview
Elite Pharmaceuticals, Inc. is a distinguished specialty pharmaceutical company focused on the development, manufacturing, and marketing of oral, controlled-release, and generic pharmaceuticals. The company is actively involved in two major pharmaceutical segments: Abbreviated New Drug Applications (ANDAs) for Generic Pharmaceuticals and New Drug Applications (NDAs) for Branded Pharmaceuticals. Since its inception in 1997, Elite Pharmaceuticals has been committed to providing advanced therapeutic solutions and has established itself as a player in the pharmaceutical industry with a robust product portfolio and a pipeline of developed drugs. Headquartered in Northvale, New Jersey, Elite Pharmaceuticals strives to address the needs of patients across various therapeutic areas with its innovative drug delivery technologies and manufacturing capabilities.
Products and Services
Elite Pharmaceuticals offers a comprehensive range of generic and branded pharmaceutical products targeting a variety of therapeutic areas. The company leverages its expertise in oral dose pharmaceuticals to serve the bariatric, pain management, cardiovascular, central nervous system, muscle relaxant, antipsychotic, and antibiotic sectors, among others. Below is an outline of their key products and services:
- Phentermine HCl 37.5mg tablets, and 15mg and 30mg capsules - Marketed under the Adipex-P brand, these products are designed for bariatric use, aiding in weight loss.
- Phendimetrazine Tartrate 35mg tablets - Available under the Bontril brand, this medication is also intended for bariatric use, specifically for weight loss.
- Naltrexone HCl 50mg tablets - Branded as Revia, these tablets are prescribed for pain management.
- Isradipine 2.5mg and 5mg capsules - Aimed at treating cardiovascular diseases, these capsules help manage blood pressure.
- Trimipramine Maleate Immediate Release capsules - Sold under the Surmontil brand, these capsules are used as antidepressants.
- Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Immediate Release tablets - Known under the Adderall brand, and its extended-release variant under the Adderall XR brand, these products target central nervous system diseases, specifically for managing ADHD symptoms.
- Dantrolene Sodium capsules - Marketed as Dantrium, these capsules function as muscle relaxants.
- SequestOX - An innovative formulation combining immediate-release Oxycodone with Naltrexone for pain management.
- Loxapine Succinate capsules - Offered under the Loxapine brand, these capsules are utilized for their antipsychotic properties.
- Acetaminophen and Codeine Phosphate - A combination used for the management of mild to moderate pain.
- Antibiotic Products - Elite Pharmaceuticals also develops antibiotic products aiming to combat various infections.
In addition to its comprehensive portfolio, Elite Pharmaceuticals actively engages in the contract manufacturing of controlled-release products for third-party clients, covering pain, allergy, bariatric, attention deficit, and infection therapies. Furthermore, the company is at the forefront of developing abuse-deterrent opioid products, reflecting its commitment to addressing the ongoing opioid crisis while meeting medical needs.
Contact Information
